Living with advanced gastrointestinal cancer—such as colorectal or gastric cancer—can feel overwhelming. When standard treatments no longer work as expected, many patients and families are left searching for new options that offer both effectiveness and quality of life.
Fruquintinib is a targeted cancer medicine developed in China that is bringing renewed hope to patients around the world.
What Is Fruquintinib?
Fruquintinib is an oral targeted therapy, which means it is taken by mouth and works differently from traditional chemotherapy.
Instead of attacking all rapidly dividing cells, fruquintinib focuses on cutting off the blood supply that tumors need to grow. By doing so, it helps slow or stop cancer progression while reducing unnecessary harm to healthy cells.
Who May Benefit from Fruquintinib?
Fruquintinib has been studied and used in patients with:
It may be an option for patients who have already received chemotherapy or other targeted treatments and are looking for a new path forward.
Your doctor can help determine whether fruquintinib is right for you.
What Benefits Have Patients Seen?
In large international clinical studies and real-world use, fruquintinib has helped many patients:
Some patients have experienced meaningful tumor shrinkage or long-lasting disease control, even after multiple previous treatments.
Taken at Home, Integrated into Daily Life
Fruquintinib is taken orally, allowing many patients to continue treatment at home rather than in the hospital. This can reduce the burden of frequent clinic visits and help patients maintain a more normal daily routine.
What About Side Effects?
Like all cancer treatments, fruquintinib may cause side effects. The most commonly reported ones include:
Most side effects are predictable and manageable with regular monitoring and timely care. Doctors can adjust the dose if needed to help patients stay on treatment safely.
Always talk to your healthcare team if you notice any changes during treatment.
Developed in China, Trusted Worldwide
Fruquintinib is a China-developed innovative medicine that has been studied in global clinical trials and used by patients in many countries. Its development reflects a growing commitment to bringing high-quality, science-based cancer treatments to patients everywhere.
Looking Ahead with Confidence
Cancer treatment is evolving, and new options are creating new possibilities. Fruquintinib can be used alone or together with other therapies, helping doctors design treatment plans tailored to each patient’s needs.
For many patients, fruquintinib represents not just another treatment—but another chance.
Talk to Your Doctor
Every patient’s journey is unique. If you or a loved one is living with advanced gastrointestinal cancer, ask your doctor whether fruquintinib could be part of your treatment plan.
DengyueMed, a Chinese pharmaceutical import and export wholesaler, is committed to advancing global health by promoting the international circulation of innovative anticancer drugs, providing valuable treatment options for patients worldwide.
Hope begins with knowledge. Options begin with conversation.